RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Urogen Pharma ROA 2024

Urogen Pharma ROA

-0.57

Urogen Pharma Dividend yield

Ticker

URGN

ISIN

IL0011407140

WKN

A2DTCV

In 2024, Urogen Pharma's return on assets (ROA) was -0.57, a -29.17% increase from the -0.81 ROA in the previous year.

Urogen Pharma Aktienanalyse

What does Urogen Pharma do?

Urogen Pharma Ltd is a biopharmaceutical company specializing in the development and marketing of innovative therapies for urological diseases. The company was founded in Israel in 2004 and is headquartered in Ra'anana. Answer: Urogen Pharma Ltd is a biopharmaceutical company specializing in the development and marketing of innovative therapies for urological diseases. Urogen Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Urogen Pharma's Return on Assets (ROA)

Urogen Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Urogen Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Urogen Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Urogen Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Urogen Pharma Stock

What is the Return on Assets (ROA) of Urogen Pharma this year?

The Return on Assets (ROA) of Urogen Pharma is -0.57 undefined this year.

What was the ROA of Urogen Pharma compared to the previous year?

The ROA of Urogen Pharma has increased by -29.17% compared to the previous year.

What consequences do high ROA have for investors of Urogen Pharma?

A high ROA is advantageous for investors of Urogen Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Urogen Pharma?

A low ROA can be unfavorable for investors of Urogen Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Urogen Pharma affect the company?

An increase in ROA of Urogen Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Urogen Pharma impact the company?

A reduction in the ROA of Urogen Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Urogen Pharma?

Some factors that can influence the ROA of Urogen Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Urogen Pharma important for investors?

The ROA of Urogen Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Urogen Pharma take to improve ROA?

To improve ROA, Urogen Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Urogen Pharma pay?

Over the past 12 months, Urogen Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Urogen Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Urogen Pharma?

The current dividend yield of Urogen Pharma is .

When does Urogen Pharma pay dividends?

Urogen Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Urogen Pharma?

Urogen Pharma paid dividends every year for the past 0 years.

What is the dividend of Urogen Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Urogen Pharma located?

Urogen Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Urogen Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Urogen Pharma from 5/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Urogen Pharma pay the last dividend?

The last dividend was paid out on 5/8/2024.

What was the dividend of Urogen Pharma in the year 2023?

In the year 2023, Urogen Pharma distributed 0 USD as dividends.

In which currency does Urogen Pharma pay out the dividend?

The dividends of Urogen Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Urogen Pharma

Our stock analysis for Urogen Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Urogen Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.